Related Experiment Video
Updated: Nov 12, 2025

06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.5K
Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention
Katherine J Kunkel1, Mohammed Ferras Dabbagh2, Mohammad Zaidan1
1Interventional Cardiology, Henry Ford Hospital, 2799 West Grand Boulevard, K-2, Detroit, MI 48202, USA.
Interventional Cardiology Clinics
|March 22, 2021
Summary
Mechanical circulatory support (MCS) is increasingly used in high-risk percutaneous coronary intervention (PCI). However, current evidence from limited studies does not consistently demonstrate improved outcomes for routine MCS use in these complex patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Growing population of patients deemed inoperable or high-risk for traditional surgical revascularization.
- Increasing utilization of mechanical circulatory devices for high-risk elective percutaneous coronary intervention (PCI).
- Predominance of observational and retrospective data in evaluating outcomes for high-risk PCI.
Purpose of the Study:
- To evaluate the evolving role and clinical outcomes of mechanical circulatory support (MCS) in high-risk PCI.
- To assess the effectiveness of routine MCS in patients with significant coronary artery disease and impaired ejection fraction undergoing PCI.
Main Methods:
- Review of existing literature, including observational, retrospective, and limited prospective randomized studies.
- Analysis of data pertaining to patient populations with high burden of coronary artery disease and reduced ejection fraction.
Main Results:
- Limited prospective randomized studies have not shown consistent improvement in clinical outcomes with routine MCS.
- Current evidence base is largely derived from non-randomized, retrospective analyses.
Conclusions:
- The optimal application of MCS in high-risk PCI remains under investigation.
- Further research is needed to define specific patient subgroups who benefit most from MCS during high-risk PCI.
- The role of MCS in high-risk PCI is dynamic and evolving with improved understanding of patient selection.

